Have a personal or library account? Click to login
Incidence and prevention of post-immunisation bleeding complications in people with haemophilia at a treatment centre in India Cover

Incidence and prevention of post-immunisation bleeding complications in people with haemophilia at a treatment centre in India

Open Access
|Jun 2025

Figures & Tables

Figure 1.

Distribution of site of bleeding complications (%)
Distribution of site of bleeding complications (%)

Figure 2.

Shift in route of vaccination (%)
Shift in route of vaccination (%)

Figure 3.

Reasons for not taking vaccination (n=14)**It is to be noted that this table the participants may have more than one reason for not taking vaccination. The data includes all the options mentioned by the participants.
Reasons for not taking vaccination (n=14)**It is to be noted that this table the participants may have more than one reason for not taking vaccination. The data includes all the options mentioned by the participants.

Immunisation schedule criteria established by the Ministry of Health and Family Welfare, India [8]

VACCINETIME TO ADMINISTERDOSEROUTESITEINTRODUCTION TIME IN INDIA (MHFW)
HBVAt birth0.5mlIntramuscularAnterolateral side of mid-thigh2002
HBV 1,2,36 weeks, 10 weeks, 14 weeks0.5mlIntramuscularAnterolateral side of mid-thigh1970s
DTwP/DTaP 1,2,36 weeks, 10 weeks, 14 weeks0.5mlIntramuscularAnterolateral side of mid-thigh
Hib6 weeks, 10 weeks, 14 weeks0.5mlIntramuscularAnterolateral side of mid-thigh2008
DTwP/DTaP booster 116-18 months0.5mlIntramuscularAnterolateral side of mid-thigh1970
DTwP/DTaP booster 24-6 years0.5mlIntramuscularUpper arm
TT10 years and 16 years0.5mlIntramuscularUpper arm1970

Frequency and percentage distribution of demographic characteristics of study participants (n=65)

VARIABLEFREQUENCY (F)PERCENTAGE (%)
Age (years)
<102233.8
11-202233.8
>212132.3
Education
No schooling710.7
Primary1218.4
Secondary1929.2
Higher secondary913.8
University1827.6
Age at diagnosis (years)
0-24670.7
3-5812.3
Over 51116.9
Type of haemophilia
Haemophilia A5584.6
Haemophilia B1015.3
Disease severity
Mild34.6
Moderate1523
Severe4772.3
Family history of haemophilia
Yes3046.1
No3553.8

Frequency and percentage distribution of prophylactic measures to prevent complications after vaccination

ITEMFREQUENCY (N)PERCENTAGE (%)
Have you/your child received vaccination? (n=79)
Yes6582.2
No1417.7
Did you have any bleeding complications after the vaccination? (n=65)
Yes1523.1
No5076.9
If yes, how was it managed? (n=15)
Factor injection913.8
Icepack and compression69.2
Did you receive any clotting factor replacement therapy before your vaccination? (n=65)
Yes3756.9
No2843.1
Route of administration of first vaccination? (n=65)
Subcutaneous5483.1
Intramuscular1116.9
Language: English
Page range: 57 - 64
Published on: Jun 7, 2025
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year

© 2025 Tenzin Zompa, Sandra Mary Abraham, Tenzin Tseten, Tenzin Palkyi, Alfiya Muhammed, MV Archana, Raghavendra Nayak, Sulochana Badagabettu, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.